Vijay K. Pandey

P.r
Shenzhen, 518055, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Corrigendum to "Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition" [Phytomedicine, February 2024, 155309, Volume 124].

Corrigendum to "Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition" [Phytomedicine, February 2024, 155309, Volume 124].

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 09, 2026

Correction to "Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on Two-Dimensional Boron Nitride Platform".

Correction to "Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on Two-Dimensional Boron Nitride Platform".

Journal: ACS nano

Published: February 25, 2026

Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on a Two-Dimensional Boron Nitride Platform.

Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on a Two-Dimensional Boron Nitride Platform.

Journal: ACS nano

Published: December 10, 2025

Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment.

Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment.

Journal: Molecular cancer

Published: October 09, 2025

PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy.

PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy.

Journal: Autophagy

Published: August 28, 2025

Electron-Withdrawing Hexagonal Boron Nitride as a Biocompatible and Metal-Free Antibacterial Platform.

Electron-Withdrawing Hexagonal Boron Nitride as a Biocompatible and Metal-Free Antibacterial Platform.

Journal: Nano letters

Published: February 21, 2025

Mitochondrial function, cell viability, pharmacokinetics and molecular simulation studies reveal the impact of CX-6258 HCl, a pan-Pim kinase inhibitor, on adipocytes.

Mitochondrial function, cell viability, pharmacokinetics and molecular simulation studies reveal the impact of CX-6258 HCl, a pan-Pim kinase inhibitor, on adipocytes.

Journal: Journal of biomolecular structure & dynamics

Published: February 12, 2025

Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4.

Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4.

Journal: Frontiers in cell and developmental biology

Published: January 19, 2025

Current Bioinformatics Tools in Precision Oncology.

Current Bioinformatics Tools in Precision Oncology.

Journal: MedComm

Published: December 12, 2024

Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Journal: Cell death & disease

Published: August 27, 2024

TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.

TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.

Journal: Life sciences

Published: July 31, 2024

A 3.55-µm Ultrathin, Skin-Like Mechanoresponsive, Compliant, and Seamless Ionic Conductive Electrode for Epidermal Electrophysiological Signal Acquisition and Human-Machine Interaction.

A 3.55-µm Ultrathin, Skin-Like Mechanoresponsive, Compliant, and Seamless Ionic Conductive Electrode for Epidermal Electrophysiological Signal Acquisition and Human-Machine Interaction.

Journal: Exploration (Beijing, China)

Published: July 30, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026